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Available online 17 September 2011AbstractIntroduction: Acute myocardial infarction (MI) significantly contributes to mortality and morbidity in developed and developing countries. ECG
can readily diagnose ST-elevation myocardial infarction (STEMI) to allow myocardium-saving interventions; however, ECG is not effective for
diagnosing patients with non-ST-elevation myocardial infarction (NSTEMI).
Purposes: We performed this study to compare NSTEMI patients to their STEMI counterparts to find useful clues that may be helpful for early
diagnosis of NSTEMI.
Methods: We reviewed the patients who received percutaneous coronary intervention (PCI) in our hospital from January 1st 2009 to May 31st
2010. Acute MI was diagnosed based on the clinical manifestation, ECG, and a rise in cardiac markers. Acute MI patients were classified as
either STEMI or NSTEMI. Their chronographs, coronary risks, co-morbidity, ECG, echocardiogram, angiographic findings, interventions, and
short-term outcomes were collected. We used the Student’s t-test, a chi-squared test, and the multivariate logistic regression analysis to compare
the STEMI and NSTEMI patients; p < 0.05 was defined to be statistically significant.
Results: There were 417 patients who received PCI, and 175 (42.0%) of them were diagnosed to have acute MI. There were 168 patients enrolled
for analysis: 104 patients (61.9%) had STEMI and 64 (38.1%) had NSTEMI. The male/female ratio was greater in STEMI (4.0 vs 1.9;
p ¼ 0.041). A higher percentage of NSTEMI patients had end-stage renal diseases (p < 0.001), or cerebrovascular diseases (p ¼ 0.030), and
received coronary intervention (p ¼ 0.015) before the index MI. NSTEMI patients had less wall motion abnormality (p ¼ 0.0045). The left
anterior descending artery was the most common culprit artery; however, the left circumflex artery was involved more commonly in NSTEMI
than in STEMI (p < 0.001). Among NSTEMI patients, 22 (34.4%) had ST depression. Forty-two had other ECG changes: T wave abnormalities
(33; 51.6%), poor R-wave progression (4; 6.3%), atrial fibrillation (3; 4.7%), bundle branch block (2; 3.1%), frequent PVCs (1; 1.6%), and
asystole (1; 1.6%). One patient displayed no change (1; 1.6%).
Conclusion: Early diagnosis is the first step of successful treatment in acute MI. Although new diagnostic methods are continuously developed,
the 12-lead body surface ECG remains the single most important initial clinical test for myocardial ischemia and infarction. For potential
NSTEMI patients, we should obtain serial ECGs for comparison. Expert consultation, assisted by bedside echocardiography, and laboratory
measurement of cardiac markers, should be undertaken without delay once dynamic, though subtle, ECG changes are found.
Copyright  2011, Taiwan Society of Emergency Medicine. Published by Elsevier Taiwan LLC. All rights reserved.
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Acute myocardial infarction (MI) significantly contributes
to mortality and morbidity in developed and developing
countries. To reduce mortality and morbidity, rapid clinical
determination of the likelihood of obstructive coronary artery* Corresponding author. Department of Emergency Medicine, Chiayi
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doi:10.1016/j.jacme.2011.08.001diseases with subsequent management is necessary for all
patients with chest discomfort or other symptoms suggestive
of an acute coronary syndrome (ACS).1e3 Timely procession
from the emergency department (ED) through to hospital
discharge improves the outcome for ACS patients.4 Although
there are increasing numbers of methods with which to diag-
nose acute MI, electrocardiography (ECG) is considered
a quick, easily accessible tool, and is the single most important
initial clinical test for diagnosing myocardial ischemia and
MI.5 A 12-lead ECG has been at the center of decision-makingMedicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
Comparison of STEMI and NSTEMI patients: demographics, coronary risks,
other co-morbidities, and presenting symptoms
STEMI NSTEMI p
Demographics and risk factors
Patients (n) 104 64
Sex (M/F) 83/21 ¼ 4.0 42/22 ¼ 1.9 0.041
Age (y)
Mean  SD 62.0  13.2 64.3  13.3 0.915
IQR 51e72 54e75
Length of stay (d, IQR) 4e7 4e7
Major CAD risks*, n (%) 2.6  1.0 2.2  1.1 0.191
BMI (kg/m2) 24.6  4.1 24.8  3.9 0.669
Chest pain, n (%) 89 (85.6%) 48 (75.0%) 0.086
Co-morbidity
Previous PCI, n (%) 9 (8.7%) 14 (21.9%) 0.015
Previous CABG, n (%) 0 (0.0%) 2 (3.1%) 0.144
Chronic renal disease, n (%) 27 (26.0%) 9 (14.1%) 0.051
ESRD, n (%) 1 (1.0%) 10 (15.6%) 0.001
Cancer, n (%) 6 (5.8%) 3 (4.7%) 1.000
CVD, n (%) 9 (8.7%) 13 (20.3%) 0.030
Atrial fibrillation, n (%) 10 (9.6%) 10 (15.6%) 0.243
*Major CAD risks include arterial hypertension, diabetes mellitus, hyperlip-
idemia, and cigarette smoking. IQR ¼ interquartile range.
Table 2
ECG changes in the corresponding lead in NSTEMI patients
ECG changes Patients, n (%)
ST depression 22 (34.4)
Exact ST depression 12 (18.8)
Reciprocal changes 10 (15.6)
Other ECG changes 42 (65.6)
T-wave abnormalities 33 (51.6)
Poor R-wave progression 4 (6.3)
Atrial fibrillation with rapid ventricular response 3 (4.7)
Bundle branch block 2 (3.1)
Asystole 1 (1.6)
Frequent PVCs 1 (1.6)
Abnormal ECG, but no change 1 (1.6)
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since 1997.6 ST-segment elevation MI (STEMI) can easily be
diagnosed from clinical manifestation and typical ECG
changes. With STEMI, the on-duty cardiologist can be notified
early when the patient is brought to the ED. However, non-ST-
segment elevation MI (NSTEMI) requires further workup and
observation. The cardiologist is usually called when the
patient is persistently symptomatic despite treatment, espe-
cially when elevated cardiac markers are subsequently re-
ported. We conducted this study to compare NSTEMI and
STEMI patients in a search for useful clues that may help in
early diagnosis of NSTEMI in the ED.
2. Methods
This is a tertiary referral center with an annual census of
105,000 emergency visits. We retrospectively reviewed ED
patients aged 18 years or older who received primary percu-
taneous coronary intervention (PCI) from January 1, 2009 to
May 31, 2010 after obtaining permission from our Institutional
Review Board. Acute MI was diagnosed based on clinical
manifestation, ECG, and an increase in cardiac marker levels.
Patients who had been previously enrolled in this study were
not eligible for re-enrollment. Acute MI patients were classi-
fied as either STEMI or NSTEMI based on the ECG. Data on
demographic characteristics, body mass index, major risks for
coronary artery diseases (CAD), co-morbidities, ECG, echo-
cardiogram, angiographic findings, interventions, and 30-day
short-term outcomes were collected. We used Student’s t-test
for continuous variables, a c2 test for categorical variables,
and multivariate logistic regression analysis for risk factors in
comparing STEMI and NSTEMI patients; p < 0.05 was
defined as statistically significant.
3. Results
There were 417 patients who received PCI, 175 (42.0 %) of
whom were diagnosed as having acute MI. Of these, 168
patients were enrolled for analysis after excluding those who
were transferred back to another facility after intervention or
who were lost during follow-up. Of the study patients, 104
(61.9%) were diagnosed with STEMI and 64 (38.1%) with
NSTEMI (Table 1). The male/female ratio was greater in
STEMI (4.0 vs. 1.9; p ¼ 0.041). There were no differences in
age, length of stay, or body mass index between STEMI and
NSTEMI patients. Although major CAD risks and chest pain
were more frequent among STEMI patients, the differences
did not reach statistical significance (CAD risks: 2.6  1.0 in
STEMI, 2.2  1.1 in NSTEMI, p ¼ 0.191; chest pain: 85.6%
in STEMI, 75.0% in NSTEMI, p ¼ 0.086). With regard to co-
morbidities apart from major CAD risks, more NSTEMI
patients needed replacement dialysis for end-stage renal
disease ( p < 0.001) or had cerebrovascular diseases
( p ¼ 0.030), but there was no difference in malignancy,
chronic kidney diseases, or atrial fibrillation. More NSTEMI
patients had received coronary intervention before the index
MI (21.9% vs. 8.7%, p ¼ 0.015). It was difficult to compareprevious coronary artery bypass surgery because of the limited
number of relevant cases.
Identification of ST-segment elevation in body-surface
ECGs is straightforward; however, NSTEMI patients had
various and sometimes ambiguous ECG findings (Table 2).
Among NSTEMI patients, 22 (34.4%) had ST depression that
may have been true ST depression or reciprocal changes.
Forty-two had other ECG changes, including T-wave abnor-
malities (n ¼ 33; 51.6%), poor R-wave progression (n ¼ 4;
6.3%), atrial fibrillation (n ¼ 3; 4.7%), bundle branch block
(n ¼ 2; 3.1%), frequent premature ventricular activity (n ¼ 1;
1.6%), and asystole (n ¼ 1; 1.6%). In one patient, no change
could be identified (1.6%).
On echocardiographs, NSTEMI patients had fewer
instances of and milder wall-motion abnormality ( p¼ 0.0045).
Coronary angiography revealed that the left anterior descend-
ing (LAD) artery was the most common culprit artery in both
STEMI (54.8%) and NSTEMI patients (40.6%); however, the
left circumflex (LCx) artery played a more important role in
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With regard to short-term outcome, MI and peripheral artery
diseases were more frequent in NSTEMI patients, whereas
more deaths occurred in STEMI patients. However, these
differences did not reach statistical significance (Table 3).
4. Discussion
“Time is myocardium, myocardium is life” is an aphorism
that captures the urgency required in MI diagnosis. Early
reperfusion of an obstructed coronary artery can reduce both
mortality and morbidity from acute MI. Primary PCI is the
preferred reperfusion therapy if it can be performed by an
experienced cardiologist within 90 minutes of the first medical
contact, especially for patients with STEMI.7,8 Thrombolytic
therapy in a timely manner is an alternative in the pre-hospital
setting, or when primary PCI is not available in the receiving
hospital.9,10 Facilitated PCI is a combination of quick-start
clot-dissolving medication followed by primary PCI; this
can result in more complete ST-segment resolution in STEMI,
although improved outcomes have not been proven in
comparison with primary PCI.11,12 All of the above
approaches involve rapid diagnosis and treatment.
The results of our study demonstrate that acute MI remains
a disease of middle-aged adults. Although three-quarters of
our patients were male, more NSTEMI patients were female.
Before the index MI, our NSTEMI patients had significantly
more cardiac, cerebrovascular, and end-stage renal diseases, in
agreement with the literature.13,14 These patients presented
more frequently without chest pain. Although these differ-
ences did not reach statistical significance in our study, a high
index of suspicion is warranted for patients potentially expe-
riencing a silent MI. There were no differences in age, major
CAD risks, body mass index, malignancy, or atrial fibrillation.
Although 12-lead body-surface ECG is a simple examina-
tion, it stands at the center of decision-making for patients withTable 3
Comparison of STEMI and NSTEMI patients: wall motion, culprit artery of
infarction, and short-term outcome
STEMI, n (%) NSTEMI, n (%) p
Wall motion abnormality
No abnormality 16 (15.4) 22 (34.4) 0.0045
Hypokinesia 48 (46.1) 31 (48.4)
Akinesia 22 (21.2) 8 (12.5)
Dyskinesia 18 (17.3) 3 (4.7)
Culprit coronary artery territory
RCA 42 (40.4) 18 (28.1) <0.001
LAD 57 (54.8) 26 (40.6)
LCx 5 (4.7) 18 (28.1)
LM 0 (0.0) 2 (3.2)
Short-term prognosis
Death 5 (4.8) 2 (3.1) 0.710
AMI recurrence 2 (1.9) 2 (3.1) 0.636
PCI 6 (5.8) 4 (6.3) 1.000
CABG 0 (0.0) 0 (0.0) NA
Heart failure 14 (13.5) 9 (14.1) 0.912
PAOD 4 (3.8) 5 (7.8) 0.304chest pain for whom ischemia is suspected. It can be used as
a screening tool because a significant segment of the acute MI
patient population presents without chest pain.15,16 A 12-lead
ECG can be used to stratify risk, identify the infarct-related
coronary artery, and predict outcomes in some cases.6,17,18
Although ECG interpretation of ST elevation or depression is
straightforward, there are several subtle ECG changes of which
physicians need to be aware for early diagnosis of acute MI.
Prominent T waves may be the only ECG abnormality in the
early stage of STEMI, although some other conditions such as
hyperkalemia, left ventricular hypertrophy, and early repolari-
zation need to be differentiated.19,20 Acute MI with bundle
branch block (BBB) carries a much worse prognosis than acute
MI without BBB.21 A left BBB is notorious in masking
ischemic changes in acute MI.22 A right BBB, although once
thought not to mask the diagnosis of acute MI, causes even
more interference.23 It has been reported that abnormal Twaves,
especially T-wave inversions of >5 mm, in patients with
potential ACS are associated with higher rates of cardiovascular
events.24 Aside from the above ECG abnormalities, some of our
NSTEMI patients had less obvious T-wave changes. These ECG
changes, although subtle, could be identified when a series of
ECGs were obtained to check for evolving changes.25,26
Aside from the 12-lead ECG, echocardiography is another
easily accessible bedside examination that can increase the
sensitivity of MI diagnosis, especially in locations supplied by
the distal RCA and some branches from the LCx that are not
monitored by any standard ECG leads.27 Echocardiography,
with a stress echo as required, is helpful when the ECG is
equivocal or complications of acute MI are suspected.28,29
Laboratory measurement of a troponin or sensitive troponin
I assay can provide additional information for the early
diagnosis of acute MI.30,31
Coronary arteriography showed that the LAD was the
major culprit coronary artery in the context of MI among our
patients. However, there was a greater LCx contribution in
NSTEMI compared to STEMI patients. The infarction terri-
tory was less extensive in NSTEMI than in STEMI patients,
and less wall-motion abnormality was observed, as revealed
by echocardiography. However, the short-term prognosis was
no better in patients with NSTEMI than in those with STEMI.
This suggests that NSTEMI patients have prognoses similar to
those of STEMI patients, so they should be treated as seriously
as STEMI patients.1,13,14
5. Limitation
This was a retrospective cohort study of patients with
a discharge diagnosis of acute MI. We found some important
clinical manifestations, co-morbidities, and ECG abnormali-
ties in NSTEMI patients. However, it is not necessary to treat
these clinical manifestations as risk factors before more
patients with these characteristics but without acute MI are
enrolled.
Patients enrolled in the study came from a single hospital. A
regional, or even national, study should be undertaken before
the results can be extrapolated to the general population.
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Early diagnosis is the first step in successful treatment of
acute MI. Although new diagnostic methods are continuously
evolving, the 12-lead body-surface ECG, a quick and easily
accessible test, remains the single most important initial
clinical test for myocardial ischemia and MI. STEMI patients
can be managed without difficulty; however, this is not usually
the case for NSTEMI patients. Serial ECGs should always be
obtained for comparison. Expert consultation, with bedside
echocardiography and laboratory measurement of cardiac
markers, should be undertaken without delay once dynamic
ECG changes are found, even if subtle, especially in patients
with multiple co-morbidities.References
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